Type of data | Inclusion visit | One-month follow-up phone call | After the end of patient inclusions |
---|---|---|---|
Baseline information | |||
Non-opposition to participate in the study | X | ||
Sociodemographic data | X | ||
Clinical data (including McIsaac criteria) | X | ||
Biospecimens | |||
Saliva sample (for the salivary rapid nucleic acid test) | X | ||
Double throat swab (one for the pharyngeal rapid antigen detection test, one for the composite reference standard) | X | ||
Test results | |||
Result of the salivary rapid nucleic acid test (index test)a | X | ||
Result of the pharyngeal rapid antigen detection test (comparator test)a | X | ||
Result of group A streptococcus culture and group A streptococcus PCR (reference standard)b | X | ||
Satisfaction | |||
Patient satisfaction (Likert) | X | ||
Physician satisfaction (Likert) | X | ||
Parent satisfaction (Likert) | X | ||
Antibiotic prescription | X | ||
Clinical evolution (i.e., whether the episode of pharyngitis healed, worsened, or relapsed) | X | ||
Qualitative survey for participating physicians (i.e., barriers and facilitators regarding the use of rapid tests) | Xc |